While not powered for statistical efficacy, the study showed promising trends favoring topical pravibismane plus standard of care (SoC) evaluating exploratory efficacy endpoints including complete ...

Good afternoon, and welcome to the MannKind Corporation third quarter 2024 financial results earnings call. As a reminder, ...

Q3 2024 Earnings Call Transcript November 7, 2024 MannKind Corporation beats earnings expectations. Reported EPS is $0.05, ...

having very severe limitations on both efficacy, safety and tolerability. We believe oral clofazimine has been part of the guideline since 2020 by developing an inhalation suspension, we have a great ...

ICON plc, a world-leading healthcare intelligence and clinical ... today announces that its lead clinical stage drug, FXR314 will be... at 08:07 Confluence Health Partners with KeyCare to Leverage ...

Amgen (AMGN) announced the presentation of new data across its rare disease portfolio and pipeline at the annual American College of ...

Lexaria Bioscience (LEXX) has engaged a contract research organization to perform the world’s first-ever fluorescently tagged ...

President-elect Donald Trump has picked Robert F. Kennedy Jr. to be his next secretary of the Department of Health and Human ...

College students have opportunities to bend or break the rules after leaving home. It can be dangerous for those who take ...

In a move to safeguard its dominant position in cancer treatments, Merck agreed to license a drug from a Chinese company ...